Joshua Ruch - Jan 17, 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
Director
Signature
/s/ Bridget Brown, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Jan 17, 2025
Transactions value $
$23,670
Form type
4
Date filed
1/22/2025, 05:08 PM
Previous filing
Nov 21, 2024
Next filing
Feb 7, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $23.7K +3K +37.58% $7.89 11K Jan 17, 2025 Direct F1
holding WGS Class A Common Stock 14.8K Jan 17, 2025 See Kariba LLC F2
holding WGS Class A Common Stock 30.1K Jan 17, 2025 See Rugu2 LLC F2
holding WGS Class A Common Stock 149K Jan 17, 2025 See VAAL Investment Partners Q9 LP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Stock Option (right to buy) Options Exercise $0 -3K -34.03% $0.00 5.82K Jan 17, 2025 Class A Common Stock 3K $7.89 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acquisition of Class A Common Stock from the exercise of stock option at an exercise price of $7.89 per share as described in Table II. The increase in beneficial ownership of Class A Common Stock resulting therefrom is indicated in Table I.
F2 Mr. Ruch is (i) a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP ("Q9"), (ii) a managing member of RUGU2 LLC ("RUGU2") and (iii) a managing member of Kariba LLC ("Kariba"). As such, Mr. Ruch exercises voting and investment power with respect to the shares owned by Q9, RUGU2 and Kariba. Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
F3 The option is fully vested.